Navigation Links
Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO

Madison, Wis. - In a merging of complementary companies, Cytochroma, Inc., a Canadian firm seeking to commercialize new Vitamin D products, has acquired Proventiv Therapeutics, LLC, of Madison, and the combined company is looking for an additional $25 million in venture capital from Canadian and American investors.

Proventiv was founded in Se......

Full article >>> are employee Keith H. Crawford, who will be vice president of strategic planning for Cytochroma.

Jay A. White, the new vice president of product development, is the former vice president of operations at Cytochroma.

Continuing in their present roles will be Martin Petkovich, chief scientific officer, and Jukka K. Karjalainen, vice president of clinical affairs.

Rae, Cyt......

Full article >>> F's goals," Block said in a statement.

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/29/06


Related biology technology :

1. GE Healthcare enters agreement with Canadian health authority
2. Canadian firm acquires Silicon Logic
3. Take off: Canadian biotech industry thrives
4. Merge eFilm corporate merger with Canadian firm moves ahead
5. Standard Imaging acquires Canadian PIPSpro radiation treatment technologies
6. Standard Imaging acquires Canadian PIPSpro radiation treatment technologies
7. EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products
8. BIO 2007: Wisconsin makes its presence felt
9. Tired of the spin? ExpertVoter website makes candidate selection easier
10. Whitewater makes plans for business incubator
11. Online service makes board connections
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
Breaking Biology News(10 mins):